US · Healthcare

Bavarian Nordic A/S (BVNKF)

Biotechnology

Bavarian Nordic A/S (BVNKF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BVNKF

P/E ratio

25.00

Bavarian Nordic A/S (BVNKF) — FAQ

What is BVNKF's P/E ratio?

The price-to-earnings (P/E) ratio for Bavarian Nordic A/S (BVNKF) is 25.00 (data as of 2026-05-23).

Does Bavarian Nordic A/S pay a dividend?

Dividend yield is not available in the current snapshot for Bavarian Nordic A/S (BVNKF). Check the MyAverix Finance app for the latest dividend data.

What sector is Bavarian Nordic A/S in?

Bavarian Nordic A/S (BVNKF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BVNKF listed on?

BVNKF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)